Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?

N-of-1 (Single-Patient) Trials for Statin-Related Myalgia

(2014) Tisha R. Joy et al.   ANNALS OF INTERNAL MEDICINE

Metabolic Myopathies Discovered During Investigations of Statin Myopathy

(2014) Steven K. Baker et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

An assessment by the Statin Muscle Safety Task Force: 2014 update

(2014) Robert S. Rosenson et al.   Journal of Clinical Lipidology

Assessing the Clinical Benefits of Lipid-Disorder Drugs

(2014) William R. Hiatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice

(2014) Judith A Finegold et al.   European Journal of Preventive Cardiology

Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience

(2013) Warner M. Mampuya et al.   AMERICAN HEART JOURNAL

Role of Colesevelam in Combination Lipid-Lowering Therapy

(2013) Michael R. Jones et al.   American Journal of Cardiovascular Drugs

Narrative Review: Statin-Related Myopathy

(2013) Tisha R. Joy   ANNALS OF INTERNAL MEDICINE

Discontinuation of Statins in Routine Care Settings

(2013) Huabing Zhang et al.   ANNALS OF INTERNAL MEDICINE

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update

(2013) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

Rhabdomyolysis

(2013) Janice L. Zimmerman et al.   CHEST

The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapy

(2013) T. Rhodes et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A randomized trial of coenzyme Q10 in patients with statin myopathy: Rationale and study design

(2013) Beth A. Parker et al.   Journal of Clinical Lipidology

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: A subanalysis of the USAGE study

(2013) Matthew K. Ito et al.   Journal of Clinical Lipidology

Statin myotoxicity: A review of genetic susceptibility factors

(2013) M. Needham et al.   NEUROMUSCULAR DISORDERS

No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy

(2013) Martin Prøven Bogsrud et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Cytochrome P450 drug interactions with statin therapy

(2013) XW Goh et al.   SINGAPORE MEDICAL JOURNAL

Effect of Coenzyme Q10 Supplementation on Statin-Induced Myalgias

(2012) David A. Bookstaver et al.   AMERICAN JOURNAL OF CARDIOLOGY

Coenzyme Q10 and selenium in statin-associated myopathy treatment

(2012) Jan Fedacko et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Effect of Statins on Skeletal Muscle Function

(2012) Beth A. Parker et al.   CIRCULATION

Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D

(2012) Ineke J. Riphagen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK

(2012) Gary S Collins et al.   HEART

Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients

(2012) David Sullivan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

(2012) Jerome D. Cohen et al.   Journal of Clinical Lipidology

Review of red yeast rice content and current Food and Drug Administration oversight

(2012) Lindsey Childress et al.   Journal of Clinical Lipidology

Discontinuation of statin therapy due to muscular side effects: A survey in real life

(2012) D. Rosenbaum et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population

(2011) Kandace L Amend et al.   ANNALS OF PHARMACOTHERAPY

Mechanisms of statin-induced myalgia assessed by physiogenomic associations

(2011) Gualberto Ruaño et al.   ATHEROSCLEROSIS

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference

(2011) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

Statin myopathy: A common dilemma not reflected in clinical trials

(2011) G. FERNANDEZ et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

(2011) Charles J. Glueck et al.   CURRENT MEDICAL RESEARCH AND OPINION

Update on Toxic Myopathies

(2011) F. L. Mastaglia et al.   Current Neurology and Neuroscience Reports

Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence

(2011) Yessica-Haydee Gomez Sandoval et al.   CURRENT PHARMACEUTICAL DESIGN

Managing statin-induced muscle toxicity in a lipid clinic

(2011) O. Blaier et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients

(2011) Patricia Maningat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

(2011) M. Niemi et al.   PHARMACOLOGICAL REVIEWS

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

(2010) Andrew L. Mammen et al.   ARTHRITIS AND RHEUMATISM

Tolerability of Red Yeast Rice (2,400 mg Twice Daily) Versus Pravastatin (20 mg Twice Daily) in Patients With Previous Statin Intolerance

(2009) Steven C. Halbert et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)

(2009) John C. LaRosa et al.   AMERICAN JOURNAL OF CARDIOLOGY

Non-adherence to statin therapy: a major challenge for preventive cardiology

(2009) TR Bates et al.   EXPERT OPINION ON PHARMACOTHERAPY

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

(2009) Deepak Voora et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetic predisposition to statin myopathy

(2008) Georgirene D Vladutiu   CURRENT OPINION IN RHEUMATOLOGY

Prevalence of Musculoskeletal Pain and Statin Use

(2008) Catherine Buettner et al.   JOURNAL OF GENERAL INTERNAL MEDICINE